Long-term FVII substitution in a preterm infant with severe gastrointestinal bleeding and FVII deficiency due to a homozygous donor splice mutation IVS4+1G→A

Pediatric Hematology and Oncology

Volumn 23, Issue 2, 2006, Pages 129-133

  Hennewig, U ^a   Eisert, S ^a   Wulff, K ^b   Herrmann, F H ^b   Schneider, D T ^a   Gobel U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Factor VII deficiency; Gastrointestinal bleeding; IVS4+G A homozygous; Replacement therapy

Indexed keywords

ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 7 DEFICIENCY; BRAIN HEMORRHAGE; CASE REPORT; DISEASE SEVERITY; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HOMOZYGOSITY; HUMAN; MALE; MELENA; MUTATION; NEWBORN; PREMATURITY; PREVENTION; PROPHYLAXIS; RISK ASSESSMENT; RNA SPLICING;

ALTERNATIVE SPLICING; FACTOR VII; FACTOR VII DEFICIENCY; GASTROINTESTINAL HEMORRHAGE; HOMOZYGOTE; HUMANS; INFANT; MUTATION; PREMATURE BIRTH;

EID: 31644439475     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010500457939     Document Type: Article

References (12)

1. Perry DJ. Factor VII deficiency. Br J Haematol. 2002;118:689-700.
2. Ragni MV, Lewis JH, Spero JA, Hasiba U. Factor VII deficiency. Am J Haematol. 1981;10:79-88.
3. Ingerlslev J, Kristensen HL. Clinical picture and treatment strategies in factor VII deficiency. Haemophilia. 1998;4:689-696.
4. Triplett DA, Brandt JT, Batard MA, Dixon JL, Fair DS. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis. Blood. 1985;66:1284-1287.
5. McVey JH, Takamiya O, Tamagnini G, et al. Exclusion of the first EGF domain of FVII by a splice site mutation causes lethal factor VII deficiency. Blood. 1998;92:920-926.
6. Wulff K, Hermann FH. Twenty two novel mutations of factor VII gene in FVII deficiency. Hum Mutat. 2000;15:489-496.
7. Peyvandi F, Mannucci PM, Asti D, et al. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia. 1997;3:242-246.
8. Herrmann FH, Wulff K, Auberger K, et al. Molecular biology and clinical manifestation of hereditary factor VII deficiency. Semin Thromb Hemost. 2000;26:393-400.
9. Cohen LJ, McWilliams MB, Neuberg R, et al. Prophylaxis and therapy with factor VII concentrate (human Immuno), vapor heated in patients with congenital factor VII deficiency: a summary of case-reports. Am J Haematol. 1995;50:296-276.
10. Ingerslev J, Knudsen L, Hvid I, et al. Use of recombinant factor VIIa in surgery in factor VII deficient patients. Haemophilia. 1997;3:215-218.
11. Mariani G, Testa MG, Di Paolantonio T, et al. Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiency. Vox Sang. 1999;77:131-136.
12. McVey JH, Boswell E, Mumford AD, et al. Factor VII deficiency and the FVII mutation database. Hum Mutat. 2001;17:3-17.